You are here

  • Home
  • Archive
  • Volume 6, Issue 1
  • Paraneoplastic hyperleucocytosis in a melanoma patient after initiation of ipilimumab and nivolumab combination therapy

Article metrics

Article menu

Download PDFPDF

Case Report
Paraneoplastic hyperleucocytosis in a melanoma patient after initiation of ipilimumab and nivolumab combination therapy

 

Online download statistics by month:

Online download statistics by month: December 2019 to February 2026

AbstractFullPdf
Dec 2019220
Jan 2020440
Feb 2020882
Mar 2020772
Apr 2020661
May 202012120
Jun 202016162
Jul 202011112
Aug 2020880
Sep 202021210
Oct 202025253
Nov 202012121
Dec 202013131
Jan 202119197
Feb 2021771
Mar 202112121
Apr 2021330
May 2021883
Jun 2021991
Jul 2021883
Aug 2021222
Sep 2021882
Oct 20218812
Nov 2021773
Dec 2021151517
Jan 2022892
Feb 20228103
Mar 2022683
Apr 202211124
May 202221219
Jun 202216164
Jul 202212132
Aug 202217171
Sep 2022252517
Oct 202215153
Nov 2022111317
Dec 2022661
Jan 2023112
Feb 202318194
Mar 2023563
Apr 2023666
May 2023114
Jun 2023330
Jul 2023446
Aug 2023663
Sep 2023882
Oct 2023554
Nov 2023674
Dec 2023332
Jan 202410113
Feb 2024993
Mar 2024441
Apr 2024885
May 2024332
Jun 202414134
Jul 202418194
Aug 202411102
Sep 202410108
Oct 202415156
Nov 202411122
Dec 2024667
Jan 2025111119
Feb 2025992
Mar 2025141411
Apr 202525253
May 2025101012
Jun 202511118
Jul 2025110
Sep 2025110
Nov 2025001
Feb 2026110
Total675688275